Skip to content
Congress·In Committee·5 months ago

Congress Moves to Make Doctor-Ordered PFAS Blood Tests Free for Medicare Patients Starting in 2028

Also known as: Expanding Seniors’ Access to PFAS Testing Act

Legislative Progress

✓ Filed
Review
House
Senate
President

Impacts

Positive Impacts(1)
Medicare
Helps

Key Points

  • Would add PFAS blood testing to Medicare’s covered screening and preventive services.
  • Requires that starting January 1, 2028, Medicare pays the full cost of a PFAS blood test when a doctor orders it.
  • Aims to make sure seniors don’t face out-of-pocket costs for this specific test, like copays or deductibles.
  • Defines PFAS testing as a blood test that checks the level of certain PFAS chemicals in the body.
  • This mainly affects people on Medicare, plus doctors and labs that provide the testing.
Medicare MedicaidHealthcareEnvironment

Milestones

2 milestones2 actions
Sep 26, 2025House

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Sep 26, 2025

Introduced in House

What Happens Next

Projected impacts based on AI analysis

Around the start of 2028 (as coverage begins)

Medicare billing systems apply the new payment rule for PFAS tests

Labs and clinics would bill Medicare under the rule that pays the lesser of actual charges or the preventive-services fee schedule amount, reducing patient billing for cost-sharing

Source Information

Document Type

Congressional Bill

Official Title

Expanding Seniors’ Access to PFAS Testing Act

Bill NumberHR 5571
Congress119th Congress
ChamberHouse of Representatives
Latest ActionReferred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Sponsor

Cosponsors

(2)
D: 1R: 1

Analysis generated by AI. While we strive for accuracy, this should not be considered legal or professional advice. Always verify information with official government sources.